Nephrogenic Systemic Fibrosis: Histology and Gadolinium Detection

被引:16
|
作者
Thakral, Charu [1 ]
Abraham, Jerrold L. [1 ]
机构
[1] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA
关键词
Nephrogenic systemic fibrosis; Histopathology; Gadolinium; Scanning electron microscopy; Energy dispersive x-ray spectroscopy; Mass spectrometry; Tissue analysis; Secondary ion mass spectrometry; LONG-TERM RETENTION; STAGE RENAL-DISEASE; CONTRAST AGENTS; DERMOPATHY; TISSUE; SKIN; QUANTIFICATION; INVOLVEMENT; MICROSCOPY; DEPOSITION;
D O I
10.1016/j.rcl.2009.06.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The association between gadolinium (Gd)-containing MR imaging contrast agents and the development of nephrogenic systemic fibrosis (INISF) is well recognized. The authors review the histopathologic features, methodology, and results Of analysis of tissues for Gd in NSF. Scanning electron microscopy/energy dispersive xray spectroscopy (SEM/EDS) provides sensitive detection of individual Gd-containing deposits in situ. Secondary ion mass spectroscopy has far greater sensitivity for detection of Gd than SEM/EDS and allows correlation at the cellular level. Inductively coupled plasma mass spectrometry is the recognized method for full quantitative analysis of Gd in tissues but requires destruction of the tissue and does not allow spatial correlation. In practice, the different analytic techniques provide complementary data and can be selected based on the information required.
引用
收藏
页码:841 / +
页数:15
相关论文
共 50 条
  • [11] Effects of Gadolinium Contrast Agents in Naive and Nephrectomized Rats: Relevance to Nephrogenic Systemic Fibrosis
    Grant, D.
    Johnsen, H.
    Juelsrud, A.
    Lovhaug, D.
    ACTA RADIOLOGICA, 2009, 50 (02) : 156 - 169
  • [12] Gadolinium and nephrogenic systemic fibrosis
    Grobner, T.
    Prischl, F. C.
    KIDNEY INTERNATIONAL, 2007, 72 (03) : 260 - 264
  • [13] Gadolinium and Nephrogenic Systemic Fibrosis
    Runge, Val M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2009, 192 (04) : W195 - W196
  • [14] Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm
    Perazella, Mark A.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (06) : 519 - 525
  • [15] Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue
    Wiginton, Clark D.
    Kelly, Brent
    Oto, Aytekin
    Jesse, Mary
    Aristimuno, Patricia
    Ernst, Randy
    Chaljub, Gregory
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2008, 190 (04) : 1060 - 1068
  • [16] Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis-an autopsy-based review
    Sanyal, Soma
    Marckmann, Peter
    Scherer, Susanne
    Abraham, Jerrold L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (11) : 3616 - 3626
  • [17] Nephrogenic systemic fibrosis associated with gadolinium use
    Chao, Chi-Chao
    Yang, Chih-Chao
    Hsiao, Cheng-Hsiang
    Pan, Ming-Kai
    Lin, Chin-Hsuan
    Hsieh, Sung-Tsang
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2008, 107 (03) : 270 - 274
  • [18] Gadolinium and nephrogenic systemic fibrosis: Association or causation
    Kurtkot, Jagadeesh
    Snow, Thomas
    Hiremagalur, Balaji
    NEPHROLOGY, 2008, 13 (03) : 235 - 241
  • [19] Nephrogenic systemic fibrosis: An epidemic of gadolinium toxicity
    Todd D.J.
    Kay J.
    Current Rheumatology Reports, 2008, 10 (3) : 195 - 204
  • [20] Nephrogenic systemic fibrosis
    Bardin, Thomas
    Richette, Pascal
    CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (01) : 54 - 58